Home
GSK plc

GSK plc Market Share Analysis for May 2026

GSK plc is a British multinational pharmaceutical and biotechnology company with global headquarters in London. It was established in 2000 by a merger of Glaxo Wellcome and SmithKline Beecham, which was itself a merger of a number of pharmaceutical companies around the Smith, Kline & French firm.

Health > Health - Other

Domaingsk.com

Year Founded2000

Employees> 10001

Annual Revenue> $1B

GSK plc

GSK plc (including company regionals)

gsk.com

See more website traffic and engagement information

GSK plc Revenue up to May 2026 is > 1B

revenue generated by GSK plc top domains

GSK plc top domains revenue over 3 years

Revenue for GSK plc top domains

gsk.com> 1B

See more with Sales Intelligence

Total visits to GSK plc's top domains

Understand GSK plc market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

gsk.com969.3K

See more with Sales Intelligence

Avg. visit duration in GSK plc's top domains

Analyze GSK plc engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

gsk.com00:02:10

See more with Sales Intelligence

Avg. pageviews on GSK plc's top domains

See how GSK plc keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

gsk.com4.41

See more with Sales Intelligence

GSK plc top competitors by domain

Top similar sites in May 2026, ranked by their affinity

astrazeneca.comCompany NameAstraZenecaEmployees> 10001HQUnited Kingdom, CambridgeAnnual revenue> $1BTotal visits1.4MHealth > Biotechnology and Pharmaceuticals

Top technologies used by GSK plc

These are the website technologies, by industry, used by GSK plc top domains

Advertising (7)

DoubleClick

Conversion & Analytics (5)

Google Analytics

Payment & Currencies (5)

Visa

Social (5)

Instagram

More Technologies

10

See all

News & Signals from GSK plc

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsGlaxoSmithKline had issues with alleged overcharging of scheduled formulations on Jun 24th '26.GSK Pharma has received a Rs 3.54 crore demand notice from the NPPA over alleged overcharging of scheduled formulations and plans to appeal.

NewsGlaxoSmithKline was planning to acquire Nuvalent, Inc. for $10.6B on Jun 9th '26.British pharmaceutical group GSK said today it had agreed to buy Nuvalent, a Boston-based company focused on cancer treatments, for US$10.6 billion.

NewsEngitix Ltd partners with GlaxoSmithKline.Extracellular matrix (ECM) specialist Engitix Ltd. is teaming up with GSK plc to delve into the mechanisms underlying regression of fibrosis after treatment for chronic liver disease, and identify and validate new drug targets involved in this process.